Flexibility for vial, syringe and cartridge filling
Vial filling for personalized medicines / clinical trials
Flexibility for liquid or lyophilized drug products
Your science is unique, but does your aseptic filling machine need to be? Standardized, fully automated Aseptic Filling Workcells from Vanrx allow you to bring new therapies to patients faster and do so with less risk.
Flexible or standardized? Reduced risk or speed? You don’t have to choose. Our Aseptic Filling Workcells provide fast, agile manufacturing capacity ideal for your pipeline.
What more can we say, except you’re welcome.Talk to the experts
We are not a conventional equipment manufacturer afraid to try new things. Biopharmaceutical manufacturing experts started the company to create a new type of aseptic filling system with technology as innovative as the drug products made within them.
Companies including Roche / Genentech, Moderna, and FUJIFILM Diosynth are producing clinical and commercial products with Vanrx systems. WuXi Biologics went from purchase order to their first GMP batch release in 15 months with 7 vial, syringe, and cartridge formats validated.See how Vanrx can help you succeed
Our company is currently looking for candidates for a number of roles in Engineering and Manufacturing, Sales, Finance and many more. Join Vanrx to work with smart people and amazing technology in the fast-growing and crucial biopharmaceutical industry.
Featured positions:See all current openings
Roche / Genentech, Moderna, FUJIFILM Diosynth and others are succeeding with Aseptic Filling Workcells
Find whitepapers, videos and infographics
Emergent BioSolutions provides perspective on changing existing commercial products to a new filling line and primary packaging. It took 22 months to move from purchase order to commercial manufacturing on the SA25 Aseptic Filling Workcell.Read more
March 18, 2020 - Featured
“The required dosage for many advanced therapies is very low—sometimes 0.5 mL or less. Getting the highest yield from your batch is essential, since each additional dosage treats another patient. Current and future customers will be able to serve their patients better thanks to the new Dynamic Peristaltic Pump,” explains Chris Procyshyn, CEO and co-founder of Vanrx.Read More